1. Division of Pulmonary and Critical Care Medicine, Brigham and Women’s Hospital/Harvard Medical School, Boston, MA, USA
2. COPD Program, Lovelace Respiratory Research Institute, Albuquerque, NM, USA
3. Department of Medicine, University of Parma, Parma, Italy
4. Therabron Therapeutics Inc., Rockville, MD, USA